Cadrenal therapeutics (CVKD) CEO Pham sells $131,779 in stock
NeutralFinancial Markets

Pham, the CEO of Cadrenal Therapeutics, has sold $131,779 worth of stock in the company. This move is significant as it may indicate the CEO's confidence in the company's future or a personal financial decision. Investors often scrutinize such transactions to gauge the sentiment of company leadership, which can impact stock performance.
— Curated by the World Pulse Now AI Editorial System